Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 2
2009 5
2010 3
2011 2
2012 4
2013 4
2014 3
2015 5
2016 8
2017 3
2018 8
2019 11
2020 9
2021 8
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group. Horwitz S, et al. Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Lancet. 2019. PMID: 30522922 Free PMC article. Clinical Trial.
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Réa D, Mauro MJ, Boquimpani C, Minami Y, Lomaia E, Voloshin S, Turkina A, Kim DW, Apperley JF, Abdo A, Fogliatto LM, Kim DDH, le Coutre P, Saussele S, Annunziata M, Hughes TP, Chaudhri N, Sasaki K, Chee L, García-Gutiérrez V, Cortes JE, Aimone P, Allepuz A, Quenet S, Bédoucha V, Hochhaus A. Réa D, et al. Among authors: minami y. Blood. 2021 Nov 25;138(21):2031-2041. doi: 10.1182/blood.2020009984. Blood. 2021. PMID: 34407542 Clinical Trial.
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.
Hughes TP, Mauro MJ, Cortes JE, Minami H, Rea D, DeAngelo DJ, Breccia M, Goh YT, Talpaz M, Hochhaus A, le Coutre P, Ottmann O, Heinrich MC, Steegmann JL, Deininger MWN, Janssen JJWM, Mahon FX, Minami Y, Yeung D, Ross DM, Tallman MS, Park JH, Druker BJ, Hynds D, Duan Y, Meille C, Hourcade-Potelleret F, Vanasse KG, Lang F, Kim DW. Hughes TP, et al. Among authors: minami y. N Engl J Med. 2019 Dec 12;381(24):2315-2326. doi: 10.1056/NEJMoa1902328. N Engl J Med. 2019. PMID: 31826340 Free PMC article. Clinical Trial.
Emerging Immunotherapy for Acute Myeloid Leukemia.
Tabata R, Chi S, Yuda J, Minami Y. Tabata R, et al. Among authors: minami y. Int J Mol Sci. 2021 Feb 16;22(4):1944. doi: 10.3390/ijms22041944. Int J Mol Sci. 2021. PMID: 33669431 Free PMC article. Review.
Immune-Checkpoint Blockade Therapy in Lymphoma.
Kuzume A, Chi S, Yamauchi N, Minami Y. Kuzume A, et al. Among authors: minami y. Int J Mol Sci. 2020 Jul 30;21(15):5456. doi: 10.3390/ijms21155456. Int J Mol Sci. 2020. PMID: 32751706 Free PMC article. Review.
Guest editorial: chronic myeloid leukemia.
Minami Y. Minami Y. Int J Hematol. 2018 Oct;108(4):353-354. doi: 10.1007/s12185-018-2521-4. Epub 2018 Aug 28. Int J Hematol. 2018. PMID: 30155590 No abstract available.
[Overview].
Minami Y. Minami Y. Rinsho Ketsueki. 2019;60(6):582-583. doi: 10.11406/rinketsu.60.582. Rinsho Ketsueki. 2019. PMID: 31281148 Japanese. No abstract available.
76 results